RHOT2 was significantly down-regulated (Log2FC = −1.35; p=0.003, Wilcoxon rank-sum test) in LNM-positive patients compared with LNM-negative patients in our T1 CRC cohort. Here, RHOT2 is linked to colorectal carcinoma.